These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10494046)

  • 1. Effects of paroxetine on heart period variability in patients with panic disorder: a study of holter ECG records.
    Yeragani VK; Jampala VC; Sobelewski E; Kay J; Igel G
    Neuropsychobiology; 1999 Sep; 40(3):124-8. PubMed ID: 10494046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records.
    Yeragani VK; Sobolewski E; Igel G; Johnson C; Jampala VC; Kay J; Hillman N; Yeragani S; Vempati S
    Psychiatry Res; 1998 Mar; 78(1-2):89-99. PubMed ID: 9579705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures.
    Yeragani VK; Pesce V; Jayaraman A; Roose S
    Biol Psychiatry; 2002 Sep; 52(5):418-29. PubMed ID: 12242058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder.
    Yeragani VK; Rao R
    J Psychosom Res; 2003 Dec; 55(6):507-13. PubMed ID: 14642980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxetine increases heart rate variability in panic disorder.
    Tucker P; Adamson P; Miranda R; Scarborough A; Williams D; Groff J; McLean H
    J Clin Psychopharmacol; 1997 Oct; 17(5):370-6. PubMed ID: 9315988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age on long-term heart rate variability.
    Yeragani VK; Sobolewski E; Kay J; Jampala VC; Igel G
    Cardiovasc Res; 1997 Jul; 35(1):35-42. PubMed ID: 9302345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panic disorder, autonomic nervous system and dissociation - changes during therapy.
    Prasko J; Latalova K; Diveky T; Grambal A; Kamaradova D; Velartova H; Salinger J; Opavsky J; Silhan P
    Neuro Endocrinol Lett; 2011; 32(5):641-51. PubMed ID: 22167145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autonomic regulation in patients with panic attacks based on longitudinal study data on the variability of the heart rhythm].
    Khaspekova NB; Diukova GM; Tumalaeva ZN; Alieva KhK
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(7):41-4. PubMed ID: 10441851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder.
    Yeragani VK; Pohl R; Jampala VC; Balon R; Ramesh C; Srinivasan K
    Depress Anxiety; 2000; 11(3):126-30. PubMed ID: 10875054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear measures of heart period variability: decreased measures of symbolic dynamics in patients with panic disorder.
    Yeragani VK; Nadella R; Hinze B; Yeragani S; Jampala VC
    Depress Anxiety; 2000; 12(2):67-77. PubMed ID: 11091929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractal dimension and approximate entropy of heart period and heart rate: awake versus sleep differences and methodological issues.
    Yeragani VK; Sobolewski E; Jampala VC; Kay J; Yeragani S; Igel G
    Clin Sci (Lond); 1998 Sep; 95(3):295-301. PubMed ID: 9730848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine decreases respiratory irregularity of linear and nonlinear measures of respiration in patients with panic disorder. A preliminary report.
    Yeragani VK; Rao R; Tancer M; Uhde T
    Neuropsychobiology; 2004; 49(2):53-7. PubMed ID: 14981334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y; Bakker A; Dunbar G; Judge R
    Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11-year-old boy with panic disorder responding to paroxetine.
    Tamai Y; Matsumoto H
    Tokai J Exp Clin Med; 2007 Mar; 32(1):28-9. PubMed ID: 21319053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of twenty-four hour heart rate variability in patients with panic disorder.
    McCraty R; Atkinson M; Tomasino D; Stuppy WP
    Biol Psychol; 2001 May; 56(2):131-50. PubMed ID: 11334700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y; Judge R
    Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.
    Sheehan DV; Burnham DB; Iyengar MK; Perera P;
    J Clin Psychiatry; 2005 Jan; 66(1):34-40. PubMed ID: 15669886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
    Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ
    J Psychopharmacol; 2002 Mar; 16(1):5-14. PubMed ID: 11949771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.